Literature DB >> 7857292

Induction of apoptosis by acyclic retinoid in the human hepatoma-derived cell line, HuH-7.

N Nakamura1, Y Shidoji, Y Yamada, H Hatakeyama, H Moriwaki, Y Muto.   

Abstract

HuH-7 cells, a human hepatoma-derived cell line, underwent apoptosis in response to all-trans 3, 7, 11, 15-tetramethyl- 2, 4, 6, 10, 14-hexadecapentaenoic acid, or acyclic retinoid. The retinoid-induced apoptosis was verified by a characteristic step-wise fragmentation of genomic DNA and chromatin condensation. The induction of apoptosis was detected as early as 8 hrs after the addition of the retinoid and was concentration dependent (0.1-10 microM). Neither the natural retinoid all-trans retinoic acid nor 9-cis retinoic acid induced apoptosis. These data strongly indicate that the antitumor activity of the acyclic retinoid may be partly explained by the induction of apoptosis in tumor cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7857292     DOI: 10.1006/bbrc.1995.1199

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

Review 1.  Treatment of hepatocarcinoma.

Authors:  Beatrice Gerard; Harry Bleiberg
Journal:  Curr Oncol Rep       Date:  2004-05       Impact factor: 5.075

2.  Synergistic growth inhibition in HL-60 cells by the combination of acyclic retinoid and vitamin K2.

Authors:  Junichi Kitagawa; Takeshi Hara; Hisashi Tsurumi; Soranobu Ninomiya; Kengo Ogawa; Seiji Adachi; Nobuhiro Kanemura; Senji Kasahara; Masahito Shimizu; Hisataka Moriwaki
Journal:  J Cancer Res Clin Oncol       Date:  2010-07-31       Impact factor: 4.553

3.  Unequivocal evidence for endogenous geranylgeranoic acid biosynthesized from mevalonate in mammalian cells.

Authors:  Yoshihiro Shidoji; Yuki Tabata
Journal:  J Lipid Res       Date:  2019-01-08       Impact factor: 5.922

4.  Chemoprevention against hepatocellular carcinoma.

Authors:  Jun-Ichi Okano; Yuki Fujise; Ryo Abe; Ryu Imamoto; Yoshikazu Murawaki
Journal:  Clin J Gastroenterol       Date:  2011-06-04

Review 5.  Chemoprevention of obesity-related liver carcinogenesis by using pharmaceutical and nutraceutical agents.

Authors:  Hiroyasu Sakai; Yohei Shirakami; Masahito Shimizu
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 6.  Supportive therapies for prevention of hepatocellular carcinoma recurrence and preservation of liver function.

Authors:  Taro Takami; Takahiro Yamasaki; Issei Saeki; Toshihiko Matsumoto; Yutaka Suehiro; Isao Sakaida
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

7.  Increase in plasma concentrations of geranylgeranoic Acid after turmeric tablet intake by healthy volunteers.

Authors:  Maiko Mitake; Hiroko Ogawa; Kazuo Uebaba; Yoshihiro Shidoji
Journal:  J Clin Biochem Nutr       Date:  2010-04-10       Impact factor: 3.114

8.  Phase II trial of oral beta-all trans-retinoic acid in hepatocellular carcinoma (SWOG 9157).

Authors:  F L Meyskens; J Jacobson; B Nguyen; G R Weiss; D R Gandara; J S MacDonald
Journal:  Invest New Drugs       Date:  1998       Impact factor: 3.850

9.  Acyclic retinoid in chemoprevention of hepatocellular carcinoma: Targeting phosphorylated retinoid X receptor-α for prevention of liver carcinogenesis.

Authors:  Masahito Shimizu; Yohei Shirakami; Kenji Imai; Koji Takai; Hisataka Moriwaki
Journal:  J Carcinog       Date:  2012-08-30

10.  Peretinoin, an acyclic retinoid, improves the hepatic gene signature of chronic hepatitis C following curative therapy of hepatocellular carcinoma.

Authors:  Masao Honda; Taro Yamashita; Tatsuya Yamashita; Kuniaki Arai; Yoshio Sakai; Akito Sakai; Mikiko Nakamura; Eishiro Mizukoshi; Shuichi Kaneko
Journal:  BMC Cancer       Date:  2013-04-15       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.